Therefore, CTSB can enhance cell pyroptosis by triggering inflammasomes and exacerbate CVB3‐induced myocarditis, suggesting that CTSB inhibitors could offer a promising avenue for the treatment of CVB3‐induced myocarditis. Here, CTSB is linked to myocarditis.